New Insights into Rotavirus Vaccines

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2012 Jun 16

PMID 22699445

Citations 5

Authors

Chiara Mameli

Valentina Fabiano

Gian Vincenzo Zuccotti

Affiliations

Soon will be listed here.

Abstract

Rotavirus vaccines have shown to be effective and well tolerated in clinical trials. However it's crucial to point out that immunization occurs in "real-word" conditions different from ideal clinical trial settings. Thus, the impact of rotavirus vaccines in terms of effectiveness and safety needs to be evaluated in real-world conditions. Post-licensure data regarding vaccine impact, effectiveness and safety under routine use are now available and provide a "real-world view". We reviewed published data about the impact of rotavirus vaccines in the post-licensure era.

Citing Articles

Prevalence and molecular typing of rotavirus in children with acute diarrhoea in Northeastern Colombia.

Martinez-Gutierrez M, Arcila-Quiceno V, Trejos-Suarez J, Ruiz-Saenz J Rev Inst Med Trop Sao Paulo. 2019; 61:e34.

PMID: 31269110 PMC: 6609135. DOI: 10.1590/S1678-9946201961034.

Comparative analysis of the immunogenicity of monovalent and multivalent rotavirus immunogens.

Mi K, Ou X, Guo L, Ye J, Wu J, Yi S PLoS One. 2017; 12(2):e0172156.

PMID: 28207817 PMC: 5313208. DOI: 10.1371/journal.pone.0172156.

In vitro Antiviral Activity of Rubia cordifolia Aerial Part Extract against Rotavirus.

Sun Y, Gong X, Tan J, Kang L, Li D, Vikash Front Pharmacol. 2016; 7:308.

PMID: 27679574 PMC: 5020101. DOI: 10.3389/fphar.2016.00308.

Impact of vaccination uptake on hospitalizations due to rotavirus acute gastroenteritis in 2 different socioeconomic areas of Spain.

Gimenez Sanchez F, Nogueira E, Sanchez Forte M, Ibanez Alcalde M, Cobo E, Angulo R Hum Vaccin Immunother. 2016; 12(4):1035-9.

PMID: 26810147 PMC: 4962960. DOI: 10.1080/21645515.2015.1118592.

High-Pressure Inactivation of Rotaviruses: Role of Treatment Temperature and Strain Diversity in Virus Inactivation.

Araud E, DiCaprio E, Yang Z, Li X, Lou F, Hughes J Appl Environ Microbiol. 2015; 81(19):6669-78.

PMID: 26187961 PMC: 4561716. DOI: 10.1128/AEM.01853-15.

References

Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P . Rotavirus vaccines in Belgium: policy and impact. Pediatr Infect Dis J. 2010; 30(1 Suppl):S21-4. DOI: 10.1097/INF.0b013e3181fefc51. View

Boom J, Tate J, Sahni L, Rench M, Hull J, Gentsch J . Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010; 125(2):e199-207. DOI: 10.1542/peds.2009-1021. View

Pitzer V, Viboud C, Simonsen L, Steiner C, Panozzo C, Alonso W . Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science. 2009; 325(5938):290-4. PMC: 3010406. DOI: 10.1126/science.1172330. View

Ruiz-Palacios G, Perez-Schael I, Velazquez F, Abate H, Breuer T, Clemens S . Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006; 354(1):11-22. DOI: 10.1056/NEJMoa052434. View

Clarke M, Davidson G, Gold M, Marshall H . Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Vaccine. 2011; 29(29-30):4663-7. DOI: 10.1016/j.vaccine.2011.04.109. View

Weinberg G, Payne D, Teel E, Mijatovic-Rustempasic S, Bowen M, Wikswo M . First reports of human rotavirus G8P[4] gastroenteritis in the United States. J Clin Microbiol. 2011; 50(3):1118-21. PMC: 3295162. DOI: 10.1128/JCM.05743-11. View

Fine P . Herd immunity: history, theory, practice. Epidemiol Rev. 1993; 15(2):265-302. DOI: 10.1093/oxfordjournals.epirev.a036121. View

Gurgel R, Correia J, Cuevas L . Effect of rotavirus vaccination on circulating virus strains. Lancet. 2008; 371(9609):301-2. DOI: 10.1016/S0140-6736(08)60164-6. View

Weinberger D, Malley R, Lipsitch M . Serotype replacement in disease after pneumococcal vaccination. Lancet. 2011; 378(9807):1962-73. PMC: 3256741. DOI: 10.1016/S0140-6736(10)62225-8. View

10.

Uhlig U, Kostev K, Schuster V, Uhlig H . Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010. Pediatr Infect Dis J. 2011; 30(12):e244-7. DOI: 10.1097/INF.0b013e31822d1408. View

11.

Boom J, Tate J, Sahni L, Rench M, Quaye O, Mijatovic-Rustempasic S . Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J. 2010; 29(12):1133-5. DOI: 10.1097/INF.0b013e3181ed18ab. View

12.

ORyan M, Lucero Y, Linhares A . Rotarix®: vaccine performance 6 years postlicensure. Expert Rev Vaccines. 2011; 10(12):1645-59. DOI: 10.1586/erv.11.152. View

13.

Vesikari T, Matson D, Dennehy P, Van Damme P, Santosham M, Rodriguez Z . Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006; 354(1):23-33. DOI: 10.1056/NEJMoa052664. View

14.

Kirkwood C, Boniface K, Barnes G, Bishop R . Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia. Pediatr Infect Dis J. 2010; 30(1 Suppl):S48-53. DOI: 10.1097/INF.0b013e3181fefd90. View

15.

Gurgel R, Cuevas L, Vieira S, Barros V, Fontes P, Salustino E . Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil. Emerg Infect Dis. 2008; 13(10):1571-3. PMC: 2851506. DOI: 10.3201/eid1310.070412. View

16.

Safadi M, Berezin E, Munford V, Almeida F, de Moraes J, Pinheiro C . Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil. Pediatr Infect Dis J. 2010; 29(11):1019-22. DOI: 10.1097/INF.0b013e3181e7886a. View

17.

Ward R, McNeal M, Steele A . Why does the world need another rotavirus vaccine?. Ther Clin Risk Manag. 2008; 4(1):49-63. PMC: 2503666. DOI: 10.2147/tcrm.s821. View

18.

Loughlin J, Mast T, Doherty M, Wang F, Wong J, Seeger J . Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine. Pediatr Infect Dis J. 2011; 31(3):292-6. DOI: 10.1097/INF.0b013e3182421390. View

19.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H . Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children. Pediatr Infect Dis J. 2009; 29(4):319-23. DOI: 10.1097/INF.0b013e3181c18434. View

20.

Goodson J, Masresha B, Wannemuehler K, Uzicanin A, Cochi S . Changing epidemiology of measles in Africa. J Infect Dis. 2011; 204 Suppl 1:S205-14. DOI: 10.1093/infdis/jir129. View